Imfinzi 120mg/2.4ml Injection

Rx
Manufacturer AstraZeneca
  • Fast Delivery
  • Muslim-Friendly
  • FDA Approved
  • Secure Payment
Save: RM479.59   15% OFF
From RM114/month
  • 0% InterestNo interest on eligible instalments
  • Flexible paymentsSpread your payment across monthly instalments
  • No hidden feesClear and transparent pricing
Earn 2,718 Points on this item (Log in or register to earn upon delivery)
🎟️ Available Vouchers
ELEVEN11
RM11 OFF
Min Spend RM350.00
Valid till: 11 Nov 2026
ELEVEN7
RM7 OFF
Min Spend RM250.00
Valid till: 11 Nov 2026
ELEVEN3
RM3 OFF
Min Spend RM120.00
Valid till: 11 Nov 2026
DELIVERY5
RM5 OFF
Min Spend RM120.00

Click a voucher to copy the code. Automatically applied at checkout if conditions are met.

Prescription Required

Orders placed now will be queued. A doctor will contact you on the next working day for approval.
Have questions? Chat with us on WhatsApp
Dr. Mohd Izzat Amir Bin Awang
Reviewed byDr. Mohd Izzat Amir Bin AwangDoctor of Medicine (MD), University of Mansoura - Manchester
Dr. Adeline Carol Peters
Written byDr. Adeline Carol PetersBachelor of Medicine and Bachelor of Surgery (MBBS) — Manipal Academy of Higher Education (MAHE)

Last updated:

Overview

Imfinzi 120mg/2.4ml Injection contains Durvalumab 120mg/2.4ml and is available as an injection. It is classified as a prescription medicine and may only be obtained with a valid prescription from a registered medical practitioner.

Only product, safety and handling information is published here. Anything beyond that is explained to you directly by your doctor or pharmacist as part of your consultation.

DoctorOnCall is a licensed online pharmacy. Orders for Imfinzi 120mg/2.4ml Injection are processed only after a doctor has assessed your suitability and issued a prescription, and every order is checked by a registered pharmacist before it is sent out.

Directions for Use

This medicine is prepared and administered only by trained healthcare professionals as an IV infusion, typically over about an hour, with monitoring for infusion-related reactions during and after each session.

Dosage

Dosing is determined by the treating oncologist based on body weight, the cancer being treated, and the specific regimen (alone or combined with chemotherapy or other immunotherapy), then given as a timed intravenous infusion in a hospital or specialist infusion setting.

Storage Instructions

Stored under controlled, refrigerated conditions by the pharmacy or hospital as specified by the manufacturer; not intended for home storage.

Side Effects

  • Fatigue
  • Cough and upper respiratory symptoms
  • Diarrhoea or colitis (bowel inflammation)
  • Rash or itching
  • Immune-related inflammation of organs such as the lungs (pneumonitis), liver (hepatitis), thyroid, or adrenal glands – these can occur at any time during or after treatment

Contraindications

  • Known hypersensitivity to durvalumab or any ingredient in the formulation
  • Active, uncontrolled autoimmune disease, unless specifically assessed and approved by the oncology team

Drug / Food Interactions

  • Corticosteroids and other immunosuppressants may reduce the effectiveness of durvalumab if used routinely, though they are sometimes needed to manage immune-related side effects under specialist guidance.
  • Live vaccines are generally avoided during treatment – discuss any vaccination plans with your oncology team.
  • Inform your oncology team of all medicines and supplements you are taking, and of any autoimmune conditions.

Quick Tips

  • Contact your care team immediately if you develop persistent diarrhoea, abdominal pain, new breathlessness or cough, yellowing of the skin or eyes, or unusual fatigue, as these can signal immune-related inflammation needing prompt treatment.
  • Carry a note or card indicating you are receiving immunotherapy, in case of emergency care elsewhere.
  • Attend all scheduled monitoring visits and blood tests, even between infusions.
  • Report any new symptom to your oncology team rather than waiting for your next scheduled visit, as immune-related side effects can appear at unpredictable times.

Ingredients / Active Ingredients

  • Durvalumab 120mg/2.4ml

Frequently Asked Questions

Product Specifications

BrandAstraZeneca
ManufacturerAstraZeneca
ClassificationPrescription medicine
Pack Size1s (Vial)
Shelf LifeRefer to the expiry date printed on the packaging; this medicine is stored and handled only by healthcare facilities.

Customer Reviews

Be the first to review this product.

Confirm Action
×

Are you sure?

×
×